A new device for meibomian gland debridement was safe and effective and demonstrated time and space benefits compared with conventional debridement and expression approaches, according to a study ...
Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback